Microbiological treatment failure associated with macrolide-resistant Bordetella pertussis
ASM Case Reports · 06.05.2025 · 1 (3)
DOI: 10.1128/asmcr.00093-24 ↗Kurz gefasst
Fallbericht in der Zeitschrift ASM Case Reports, erschienen am 06.05.2025. Verfasst von David Prabhakar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Infectious Diseases, Children's Hospital at Westmead, Sydney, New South Wales, Australia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSW Health.
Abstract (Originalsprache)
Background
Despite successful vaccination programs, many countries are experiencing a marked rise in pertussis cases since 2024, compounded by the emergence of macrolide-resistant Bordetella pertussis (MRBP). Here, we report the clinical, laboratory, and genomic features of MRBP isolated from a child with severe pertussis. Case Summary An 11-week-old term infant with pertussis who required intensive care unit support remained B. pertussis culture-positive despite azithromycin therapy. Pre- and post-treatment isolates demonstrated phenotypic drug resistance and carried known 23S rRNA macrolide-resistance conferring mutations.
Conclusion
The international spread of macrolide-resistant B. pertussis warrants the introduction of susceptibility testing for this pathogen.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbiology and Infectious Diseases, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
- Center for Infectious Diseases and Microbiology-Public Health, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.
- School of Medical Sciences and Sydney Infectious Diseases Institute (Sydney ID), Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Center for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Sydney, New South Wales, Australia.
ORCID-Profile: Rebecca J Rockett, Vitali Sintchenko
Förderung
- NSW Health
Zitieren
APA
Prabhakar, D., Fong, W., Sim, E. M., Howard-Jones, A. R., Nguyen, T., Dempsey, S., Rockett, R. J., Kok, J., Chen, S. C., Outhred, A. C., & Sintchenko, V. (2025). Microbiological treatment failure associated with macrolide-resistant Bordetella pertussis. ASM Case Reports, 1(3). https://doi.org/10.1128/asmcr.00093-24
Vancouver
Prabhakar D, Fong W, Sim EM, Howard-Jones AR, Nguyen T, Dempsey S, et al. Microbiological treatment failure associated with macrolide-resistant Bordetella pertussis. ASM Case Reports. 2025;1(3). doi:10.1128/asmcr.00093-24
BibTeX
@article{Prabhakar2025,
author = {Prabhakar, David and Fong, Winkie and Sim, Eby M and Howard-Jones, Annaleise R and Nguyen, Trang and Dempsey, Suzanne and Rockett, Rebecca J and Kok, Jen and Chen, Sharon C-A and Outhred, Alexander C and Sintchenko, Vitali},
title = {Microbiological treatment failure associated with macrolide-resistant Bordetella pertussis},
journal = {ASM Case Reports},
year = {2025},
volume = {1},
number = {3},
doi = {10.1128/asmcr.00093-24}
}
EUVIMED